New clinical trial data published at ESPGHAN 2019 on SMA® Alfamino® demonstrated normal growth (body weight, length and head circumference) in 220 infants with cows' milk allergy (CMA).1 SMA® Alfamino® is now supported by 3 clinical trials.1-3


OBJECTIVES
To assess if an amino acid-based formula (SMA® Alfamino®) supports normal growth in infants with CMA.
METHODS

220 infants with challenge-proven CMA were recruited from 10 clinical centres. Growth parameters (body weight, length and head circumference) were measured at enrolment, after the oral food challenge (OFC) and at final follow-up around 9 months of age. Weight-for-age, length-for-age and head circumference-for-age z scores were calculated based on WHO growth standards. In infants older than 4 months, a complementary cows' milk protein-free diet was allowed during the trial alongside SMA® Alfamino®.

RESULTS

Mean body weight, length and head circumference increased in line with WHO growth standards, confirming normal growth velocity.

CONCLUSION

Infants with challenge-proven CMA achieved normal weight gain, linear growth and head growth while being fed SMA® Alfamino®, together with a cows' milk protein-free elimination diet, during the first 9 months of life.

To read the publication, click here (page 1001).



RELATED PRODUCTS

* The factory and factory line is awaiting independent halal/kosher certification however the product contains only halal/kosher ingredients and will be now made with halal processing aids (e.g. using non-porcine enzymes for the protein hydrolysis process).

IMPORTANT NOTICE

Breastfeeding is best for babies. SMA® Althéra® and SMA® Alfamino® must only be used under strict medical supervision and after full consideration of the feeding options available, including breastfeeding. The advice of a doctor, midwife, health visitor, public health nurse, dietitian or pharmacist on the need for and proper method of use of infant milks and on all matters of infant feeding should be sought. Good maternal nutrition is important for the preparation and maintenance of breastfeeding. Introducing partial bottle-feeding may have a negative effect on breastfeeding and reversing a decision not to breastfeed is difficult. Social and financial implications should be considered when selecting a method of infant feeding. Infant milk should always be prepared and used as directed. Inappropriate foods or feeding methods, or improper use of infant formula, may present a health hazard.

 

REFERENCES
1. Nowak-Wegrzyn, A. et al. Hypoallergenicity of a whey-based, extensively hydrolyzed infant formula prepared with nonporcine enzymes. Allergy 2019, epub ahead of print.
2. Nowak-Wegrzyn, A. et al. Nutrients 2019; 11, 1447.
3. Niggemann B et al. Pediatr Allergy Immunol 2008; 194(4): 348–354.